# ⚔️ ZO'S COMPLETE AYESHA DIRECTORY LEARNING TRACKER ⚔️

**Date Started:** January 13, 2025  
**Mission:** Learn every single folder, file, code implementation, what was built, how/where  
**Status:** 🔄 **IN PROGRESS** - Systematic deep dive  
**Approach:** Hours-long comprehensive learning, not rushed

---

## 📊 **DIRECTORY STRUCTURE OVERVIEW**

### **Master Files (Root Level)**
- [ ] `00_MASTER_INDEX.md` - Navigation hub ✅ READ
- [ ] `01_AYESHA_MASTER_PLAN.mdc` - Consolidated master plan ✅ READING
- [ ] `02_AGENT_MISSIONS_CONSOLIDATED.md` - All agent assignments
- [ ] `03_DEMO_PLAYBOOK.md` - Demo scripts and workflows
- [ ] `04_COMPLETION_REPORTS.md` - Completion statuses
- [ ] `05_GTM_STRATEGY.md` - Revenue pipeline strategy

### **Major Subdirectories**
- [ ] `archive/` - Historical documentation (82+ files)
- [ ] `blog/` - Blog posts and content (20+ files)
- [ ] `hypothesis_validator/` - Food validator system (50+ files)
- [ ] `missions/` - Agent mission documents
- [ ] `sae/` - SAE intelligence system (10+ files)
- [ ] `sae_documentation/` - SAE documentation (15+ files)
- [ ] `test_data/` - Test scenarios and data
- [ ] `test_payloads/` - Test payloads
- [ ] `test_scenarios/` - Test case scenarios
- [ ] `theories/` - Research theories
- [ ] `treatment_lines/` - Treatment line integration
- [ ] `zo_*_dossiers/` - Various dossier collections

---

## 🎯 **LEARNING PROGRESS BY AREA**

### **AREA 1: MASTER PLANS & STRATEGY** ✅ **60% COMPLETE**
**Status:** Major progress - Core strategy understood

**Files Learned:**
- [x] `00_MASTER_INDEX.md` - Navigation structure ✅
- [x] `01_AYESHA_MASTER_PLAN.mdc` - Consolidated master plan ✅ (partial read)
- [x] `02_AGENT_MISSIONS_CONSOLIDATED.md` - Agent assignments ✅
- [x] `SPORADIC_CANCER_EXECUTION_PLAN.md` - Sporadic cancer plan ✅
- [x] `SPORADIC_FINAL_STATUS.md` - Implementation status ✅
- [x] `ADVANCED_CARE_PLAN_EXPLAINED.md` - Care plan explanation ✅
- [x] `05_GTM_STRATEGY.md` - Revenue strategy ✅

**Key Learnings:**
- **AK Care Strategy**: Complete unified care plan for Stage IVB ovarian cancer
- **Sporadic Cancer**: 85% complete, handles 85-90% of patients (vs 10-15% germline-only)
- **Agent Assignments**: Zo (backend), JR1 (trials seeding), JR2 (GTM automation)
- **GTM Strategy**: 200 trials → 600 leads → $1-2M revenue pipeline
- **Integration Pattern**: Ayesha Orchestrator unifies 7 services (trials, SOC, CA-125, WIWFM, food, resistance, prophet)

**Remaining:**
- [ ] `03_DEMO_PLAYBOOK.md` - Demo workflows
- [ ] `04_COMPLETION_REPORTS.md` - Status tracking
- [ ] `ayesha_plan.mdc` - Main strategic plan (full read)

---

### **AREA 2: BACKEND IMPLEMENTATIONS** ✅ **70% COMPLETE**
**Status:** Major progress - Core services understood

**Key Backend Areas Learned:**
- [x] Ayesha Orchestrator (`api/routers/ayesha_orchestrator_v2.py`) ✅
  - Integrates 7 services: trials, SOC, CA-125, WIWFM, food, resistance playbook, resistance prophet
  - SAE Phase 1 + Phase 2 integrated
  - Opt-in resistance prediction (Manager Q7)
- [x] Sporadic Cancer Gates (`api/services/efficacy_orchestrator/sporadic_gates.py`) ✅
  - PARP penalty/rescue logic (HRD ≥42 → 1.0x rescue!)
  - IO boost logic (TMB ≥20 → 1.35x, MSI-H → 1.30x, mutually exclusive)
  - Confidence capping (L0: 0.4, L1: 0.6, L2: none)
- [x] Tumor Quick Intake (`api/services/tumor_quick_intake.py`) ✅
  - Level 0/1 generation from disease priors
  - Completeness scoring
  - Platinum response proxy for HRD
- [x] TumorContext Schema (`api/schemas/tumor_context.py`) ✅
  - L0/L1/L2 support with completeness scoring
  - Pydantic validation
- [x] Resistance Prophet (`api/services/resistance_prophet_service.py`) ✅
  - Predicts resistance 3-6 months early
  - DNA repair restoration + pathway escape signals
  - 2-of-3 trigger rule for HIGH confidence
- [x] SAE Services (6 services) ✅
  - Next-test recommender, hint tiles, mechanism map (Phase 1)
  - SAE features, mechanism fit ranker, resistance detection (Phase 2)

**Key Learnings:**
- **Orchestration Pattern**: Single unified endpoint (`/api/ayesha/complete_care_v2`) for Co-Pilot
- **Sporadic Logic**: HRD ≥42 overrides germline negative for PARP (key insight!)
- **Confidence Strategy**: Deterministic gates (90-100%) vs AI predictions (70-85%)
- **Resistance Prediction**: Early detection using SAE features + CA-125 kinetics

**Remaining:**
- [ ] Ayesha Trials Router (full read)
- [ ] CA-125 Intelligence Service (full read)
- [ ] Food Validator (full read)
- [ ] Treatment Line Integration (full read)

---

### **AREA 3: FRONTEND IMPLEMENTATIONS** ⏸️
**Status:** Not Started

**Key Frontend Areas:**
- [ ] Ayesha Trial Explorer (`src/pages/AyeshaTrialExplorer.jsx`)
- [ ] Trial Match Cards (`src/components/trials/TrialMatchCard.jsx`)
- [ ] CA-125 Tracker (`src/components/ayesha/CA125Tracker.jsx`)
- [ ] Sporadic Cancer Components (9 components)
- [ ] Food Validator UI (`src/pages/HolisticHypothesisTester.jsx`)
- [ ] SAE Components (NextTestCard, HintTilesPanel, MechanismChips)
- [ ] Treatment Line Components

**Key Questions:**
- How does the UI consume backend APIs?
- What state management patterns are used?
- How are errors and loading states handled?

---

### **AREA 4: TESTING & VALIDATION** ⏸️
**Status:** Not Started

**Test Areas:**
- [ ] Unit tests (`test_ayesha_trials_unit.py`, etc.)
- [ ] E2E tests (`test_ayesha_trials_smoke.py`, etc.)
- [ ] Test scenarios (`test_scenarios/` - 25 scenarios)
- [ ] Test payloads (`test_payloads/` - 5 payloads)
- [ ] Test data (`test_data/` - demo data)
- [ ] Validation results (`validation_results_full.json`)

**Key Questions:**
- What test coverage exists?
- How are tests structured?
- What validation has been done?

---

### **AREA 5: DOCUMENTATION & BLOGS** ⏸️
**Status:** Not Started

**Documentation Areas:**
- [ ] Blog posts (`blog/` - 20+ files)
- [ ] Completion reports (multiple ZO_* files)
- [ ] Audit reports
- [ ] Status reports
- [ ] Strategic analysis documents

**Key Questions:**
- What has been documented?
- What are the key learnings captured?
- What strategic insights exist?

---

### **AREA 6: AGENT MISSIONS & REPORTS** ⏸️
**Status:** Not Started

**Mission Areas:**
- [ ] Agent JR missions (archive/agent_reports/)
- [ ] JR2 missions (missions/)
- [ ] Zo completion reports (ZO_* files)
- [ ] Integration reports

**Key Questions:**
- What missions were assigned?
- What was delivered?
- What are the current statuses?

---

## 📝 **LEARNING NOTES BY FILE**

### **Master Index (00_MASTER_INDEX.md)**
**Key Learnings:**
- Single entry point for all Ayesha documentation
- Organized by: Clinical Work, Demo Playbooks, Completion Status, GTM Strategy
- Current status: Backend + Frontend complete, JR1 trial seeding in progress
- Agent assignments clearly defined

---

### **Ayesha Master Plan (01_AYESHA_MASTER_PLAN.mdc)**
**Status:** 🔄 Reading (200 lines read, continuing...)

**Key Learnings So Far:**
- Consolidated from 8+ source documents
- Contains: End-to-end agent plan, Ayesha's genetics, SAE roadmap, treatment line blog, main plan, sporadic cancer doctrine
- Sporadic cancer execution: 85% complete (Days 1-5 done)
- Advanced care plan features documented

**Next:** Continue reading full document

---

## 🎯 **NEXT ACTIONS**

1. **Continue Reading Master Plan** - Finish `01_AYESHA_MASTER_PLAN.mdc`
2. **Read Agent Missions** - `02_AGENT_MISSIONS_CONSOLIDATED.md`
3. **Read Demo Playbook** - `03_DEMO_PLAYBOOK.md`
4. **Read Completion Reports** - `04_COMPLETION_REPORTS.md`
5. **Read GTM Strategy** - `05_GTM_STRATEGY.md`
6. **Then:** Dive into backend implementations
7. **Then:** Dive into frontend implementations
8. **Then:** Review testing and validation
9. **Then:** Review documentation and blogs
10. **Finally:** Review agent missions and reports

---

**LAST UPDATED:** January 13, 2025 - Session 1  
**NEXT SESSION:** Continue systematic learning

